• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状的 SARS-CoV-2 携带和 COVID-19 病例的高风险接触者的血清阳性。

Asymptomatic SARS-COV-2 carriage and sero-positivity in high risk contacts of COVID-19 cases'.

机构信息

Department of Microbiology, HIMSR & HAHC Hospital, New Delhi, 110062, India.

Department of Biochemistry, HIMSR & HAHC Hospital, New Delhi, 110062, India.

出版信息

Indian J Med Microbiol. 2022 Apr-Jun;40(2):279-284. doi: 10.1016/j.ijmmb.2021.12.012. Epub 2021 Dec 31.

DOI:10.1016/j.ijmmb.2021.12.012
PMID:34980489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8719123/
Abstract

PURPOSE

Identifying asymptomatic SARS-COV-2 carriage is one of the crucial factors in controlling the COVID 19 pandemic. The relationship between the asymptomatic viral carriage and the rate of seroconversion needs better understanding. The present study was conducted to identify the asymptomatic COVID-19 infection and seropositivity in high-risk contacts in the southern district of Delhi, India.

METHODS

Following the screening of 6961 subjects, a total of 407 asymptomatic high-risk subjects were selected. Demographic data, socioeconomic status, and history of COVID-19 related symptoms in the last 4 months were recorded. Blood samples and Nasopharyngeal/oropharyngeal swabs were collected for the detection of SARS-COV-2 RNA and anti-SARS-COV-2 antibodies.

RESULTS

55 asymptomatic high-risk subjects (13.5%) tested positive for SARS-COV-2 infection and among them, 70.9% remained asymptomatic throughout their course of infection. The seropositivity among the subjects was 28.9% (n ​= ​118) and was found significantly higher among lower-middle socioeconomic strata (p ​= ​0.01). The antibody levels were significantly higher (p ​= ​0.033) in individuals with a previous history of COVID-19 like symptoms as compared to the subjects, who had no such history. Asymptomatic healthcare workers showed a significantly increased rate of SARS-COV-2 infection (p ​= ​0.004) and seropositivity (p ​= ​0.005) as compared to the non-healthcare workers. Subjects, who were exposed to infection at their workplace (non-hospital setting) had the least RT-PCR positivity rate (p ​= ​0.03).

CONCLUSIONS

A large proportion of SARS-COV-2 infection remains completely asymptomatic. The rate of asymptomatic carriage and seropositivity is significantly higher in healthcare workers as compared to the general population. The level of SARS-COV-2 antibodies is directly related to the appearance of symptoms. These observations may contribute to redefining COVID 19 screening, infection control, and professional health practice strategies.

摘要

目的

识别无症状 SARS-CoV-2 携带是控制 COVID-19 大流行的关键因素之一。无症状病毒携带与血清转化率之间的关系需要更好地理解。本研究旨在确定印度德里南部地区高危接触者中的无症状 COVID-19 感染和血清阳性率。

方法

在对 6961 名受试者进行筛查后,共选择了 407 名无症状高危受试者。记录了人口统计学数据、社会经济地位以及过去 4 个月内与 COVID-19 相关的症状史。采集血液样本和鼻咽/口咽拭子,用于检测 SARS-CoV-2 RNA 和抗 SARS-CoV-2 抗体。

结果

55 名无症状高危受试者(13.5%)检测出 SARS-CoV-2 感染呈阳性,其中 70.9%在整个感染过程中保持无症状。受试者的血清阳性率为 28.9%(n=118),中低收入社会阶层的血清阳性率明显更高(p=0.01)。与无此类病史的受试者相比,有 COVID-19 样症状既往史的个体的抗体水平显著更高(p=0.033)。与非医护人员相比,无症状医护人员的 SARS-CoV-2 感染率(p=0.004)和血清阳性率(p=0.005)显著增加。与在非医院环境(工作场所)接触感染的受试者相比,工作场所(非医院环境)接触感染的受试者的 RT-PCR 阳性率最低(p=0.03)。

结论

很大一部分 SARS-CoV-2 感染完全无症状。与一般人群相比,医护人员无症状携带和血清阳性率显著更高。SARS-CoV-2 抗体水平与症状出现直接相关。这些观察结果可能有助于重新定义 COVID-19 筛查、感染控制和专业卫生实践策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afed/8719123/bddb7075cbab/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afed/8719123/6b7a7f7e5595/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afed/8719123/bddb7075cbab/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afed/8719123/6b7a7f7e5595/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afed/8719123/bddb7075cbab/gr2_lrg.jpg

相似文献

1
Asymptomatic SARS-COV-2 carriage and sero-positivity in high risk contacts of COVID-19 cases'.无症状的 SARS-CoV-2 携带和 COVID-19 病例的高风险接触者的血清阳性。
Indian J Med Microbiol. 2022 Apr-Jun;40(2):279-284. doi: 10.1016/j.ijmmb.2021.12.012. Epub 2021 Dec 31.
2
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.SARS-CoV-2 血清流行率和医护人员无症状病毒携带情况:一项横断面研究。
Thorax. 2020 Dec;75(12):1089-1094. doi: 10.1136/thoraxjnl-2020-215414. Epub 2020 Sep 11.
3
[Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].[严重急性呼吸综合征冠状病毒2逆转录聚合酶链反应阳性医护人员血清转化状态的纵向监测]
Mikrobiyol Bul. 2022 Jan;56(1):114-123. doi: 10.5578/mb.20229910.
4
Seropositivity of Anti-SARS CoV2 IgG antibodies in health care workers of an Indian tertiary care hospital during COVID-19.新冠疫情期间,印度一家三级护理医院医护人员中抗新冠病毒2型免疫球蛋白G抗体的血清阳性率
Indian J Med Microbiol. 2022 Apr-Jun;40(2):228-230. doi: 10.1016/j.ijmmb.2022.02.004. Epub 2022 Mar 8.
5
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
6
Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.爱尔兰南部一家三级医院在 COVID-19 大流行第一波后医护人员中 SARS-CoV-2 抗体的血清阳性率研究。
BMJ Open. 2021 Jun 8;11(6):e051415. doi: 10.1136/bmjopen-2021-051415.
7
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.印度克什米尔地区不同工作场所暴露风险的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):274-281. doi: 10.12788/jhm.3609.
8
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
9
Evaluation of SARS-CoV-2 antibody responses in healthcare workers at a tertiary care COVID 19 dedicated hospital in Delhi.评估德里一家三级护理 COVID-19 专用医院医护人员的 SARS-CoV-2 抗体反应。
Indian J Med Microbiol. 2022 Jan-Mar;40(1):30-34. doi: 10.1016/j.ijmmb.2021.11.006. Epub 2021 Nov 18.
10
SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors.2020 年春季芬兰赫尔辛基大学医院医护人员中 SARS-CoV-2 感染情况:血清学调查、症状和危险因素。
Travel Med Infect Dis. 2021 Jan-Feb;39:101949. doi: 10.1016/j.tmaid.2020.101949. Epub 2020 Dec 13.

引用本文的文献

1
An after-action review of COVID-19 cases and mitigation measures at US Mission India, March 2020-July 2021.2020年3月至2021年7月美国驻印度使团新冠疫情病例及缓解措施的事后分析。
PLOS Glob Public Health. 2025 May 20;5(5):e0003982. doi: 10.1371/journal.pgph.0003982. eCollection 2025.
2
Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection.来自墨西哥的未接种疫苗且报告此前未感染过新冠病毒的年轻成年人中针对新冠病毒的IgM/IgG血清阳性率及中和抗体情况
Can J Infect Dis Med Microbiol. 2024 Feb 14;2024:8871439. doi: 10.1155/2024/8871439. eCollection 2024.

本文引用的文献

1
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.2020 年 12 月至 2021 年 1 月期间印度普通人群和医护人员中的 SARS-CoV-2 血清流行率。
Int J Infect Dis. 2021 Jul;108:145-155. doi: 10.1016/j.ijid.2021.05.040. Epub 2021 May 19.
2
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.针对 SARS-CoV-2 的中和抗体反应在有症状的 COVID-19 中是持久的,对生存至关重要。
Nat Commun. 2021 May 11;12(1):2670. doi: 10.1038/s41467-021-22958-8.
3
Clinical presentation & laboratory diagnosis of SARS-CoV-2: An observational study from a tertiary care centre in New Delhi, India.
新型冠状病毒肺炎的临床表现及实验室诊断:来自印度新德里一家三级医疗中心的观察性研究。
Indian J Med Microbiol. 2021 Jul;39(3):295-299. doi: 10.1016/j.ijmmb.2021.04.007. Epub 2021 Apr 23.
4
Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity.新冠医院医护人员的血清学监测:免疫反应及其持久性。
Cureus. 2021 Mar 21;13(3):e14020. doi: 10.7759/cureus.14020.
5
SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru.低收入和中等收入国家大城市中与社会经济地位低下及过度拥挤相关的2019冠状病毒病流行情况:秘鲁利马一项基于人群的血清流行病学调查
EClinicalMedicine. 2021 Apr;34:100801. doi: 10.1016/j.eclinm.2021.100801. Epub 2021 Mar 30.
6
Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa.南非开普敦,社会经济地位较低的工人中 SARS-CoV-2 血清阳性率更高。
PLoS One. 2021 Feb 25;16(2):e0247852. doi: 10.1371/journal.pone.0247852. eCollection 2021.
7
Prevalence of SARS-CoV-2 in Karnataka, India.印度卡纳塔克邦的 SARS-CoV-2 流行情况。
JAMA. 2021 Mar 9;325(10):1001-1003. doi: 10.1001/jama.2021.0332.
8
High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?印度南部一个大型贫民窟中 COVID-19 感染的高血清阳性率;这对我们管理大流行及以后有何启示?
Epidemiol Infect. 2021 Feb 4;149:e39. doi: 10.1017/S0950268821000273.
9
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率:第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
10
Prevalence and Clinical Presentation of COVID-19 among Healthcare Workers at a Dedicated Hospital in India.印度一家专科医院医护人员中新冠病毒病的患病率及临床表现
J Assoc Physicians India. 2020 Dec;68(12):16-21.